Buy Like Buffett
Watchlist

Flagship explainer

How Core Scientific, Inc./tx makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$319M · 100%Cost of revenue$281M · 88%Gross profit$37.9M · 12%Operating income−$246M · −77%Income before tax−$288M · −90%Income tax$583000 · 0%Net income−$289M · −90%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$319M100%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
Cost of revenue$281M88%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
$37.9M12%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
−$246M−77%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
Income before tax−$288M−90%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
Income tax$5830000%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
−$289M−90%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-013305 · filed Mar 2, 2026
· event Dec 31, 2025 · retrieved Oct 18, 2026 · annual-row source set
Embed this chart

View the full Core Scientific, Inc./tx analysis at Buy Like Buffett